Home | Welcome to Contract Pharma   
Last Updated Monday, May 20 2013
Print

Custom Sourcing News

Related Searches:

Filter by:

October 2, 2007
SAFC, a member of the Sigma-Aldrich Group, plans to begin construction of a new cGMP potent active pharmaceutical ingredients (APIs) conjugation suite at its St. Louis manufacturing site. This addition will support oncology drug substance requirement…   Read More »
September 21, 2007
Bioxel Pharma, Inc. has won its largest paclitaxel order—valued at about $800,000—from a multinational pharmaceutical company that is currently completing Phase III trials for a paclitaxel-based product. Paclitaxel deliveries under the o…   Read More »
September 12, 2007
SAFC is investing $10 million to increase cGMP commercial-scale API manufacturing capacity at its SAFC Pharma, Arklow, Ireland facility, and to expand capacity to enhance manufacturing operations at its Buchs, Switzerland facilities. The company…   Read More »
September 10, 2007
AMRI opened its new 50,000-sq.-ft. R&D center at the Shapoorji Pallonji Biotech Park in Hyderabad, India. The new facility will provide additional space for the company's laboratory-scale operations in India. The new facility includes labs…   Read More »
August 31, 2007
SAFC, a member of the Sigma-Aldrich Group, has announced a $4.5 million capacity expansion program at its SAFC Pharma high-potency API (HPAPI) facility in Madison, WI. The program will add cGMP pilot plant and kilo lab capacity and complement the new…   Read More »
August 20, 2007
Alphora Research, Inc. has invested in a new pilot plant facility in an effort to increase its range of services. The company recently expanded to include a 14,000-sq.-ft. facility. The cGMP pilot plant is currently under construction and is expected…   Read More »
July 26, 2007
Thermo Fisher Scientific, Inc. has entered into an agreement to acquire Qualigens Fine Chemicals, a division of GlaxoSmithKline Pharmaceuticals (GSK India) based in Mumbai. Qualigens is a chemical manufacturer and supplier serving a variety of indust…   Read More »
July 11, 2007
Alpharma Pharmaceutical Co. has completed its agreement with Zhejiang Hisun Pharmaceutical Co. (Hisun), doubling its capacity to manufacture one of Hisun's major APIs, vancomycin, subject to FDA and European regulatory approvals. Vancomycin is for se…   Read More »
April 3, 2007
Diosynth Biotechnology has signed an agreement with Talecris Biotherapeutics for process development and cGMP production of clinical trial material for a specific form of recombinant Plasminogen. Recombinant Plasminogen is an intermediate material us…   Read More »
March 22, 2007
Vion Pharmaceuticals has extended its agreement with SAFC Pharma for the manufacture of the API in Cloretazine, an anti-cancer drug currently in a Phase III trial in combination with Ara-C for relapsed acute myelogenous leukemia (AML), and a Phase II…   Read More »
March 22, 2007
The Dow Chemical Co. has entered a strategic alliance with Colorcon, Inc. for the global marketing, sales, technical service and development, and distribution of Dow's excipient products for use in controlled release applications. The agreement appli…   Read More »
February 16, 2007
Ubichem Research, which has locations in Eastleigh, UK and Budapest, Hungary, has successfully completed its first regulatory audit and is now approved by OGYI (Hungarian National Institute for Pharmacy) for the commercial supply of cGMP Active Pharm…   Read More »
January 2, 2007
The Synthetic Organic Chemical Manufacturers Association (SOCMA) will launch a new sustainable chemistry initiative, The International Center for Sustainable Chemistry, in early 2007. The initiative is the result of a partnership between SOCMA and t…   Read More »
November 9, 2006
AMRI has implemented a plan to restructure its large scale manufacturing operations in Rensselaer, NY, following a detailed analysis of the site's processes, management, cost structure, efficiency and profitability. The restructuring plan aims to str…   Read More »
October 25, 2006
SAFC Pharma business segment, a member of the Sigma-Aldrich Group, has been appointed by Curalogic to provide protein isolation, extraction and purification services related to the development of products focused on allergic rhinitis. Curalogic…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On